ORCHARD THERAPEUTICS PLC.

In News

Slaughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin - Slaughter and May

Slaughter and May - Oct 05, 2023

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Pharmaceutical Technology - Jan 25, 2024

Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin - Yahoo Finance

Yahoo Finance - Oct 06, 2023

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics - GSK

GSK - Apr 12, 2018

Orchard turns to layoffs in cutting gene therapy research - BioPharma Dive

BioPharma Dive - Mar 30, 2022

Orchard to lose out on milestone payments as Pharming Group ends collab - The Business Journals

The Business Journals - May 08, 2024

Orchard Therapeutics: Still An Attractive Merger Arbitrage Opportunity With A CVR - Seeking Alpha

Seeking Alpha - Jan 19, 2024

Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - The Manila Times

The Manila Times - Dec 02, 2025

Kyowa goes big on Libmeldy with $477m Orchard buy - BioProcess International

BioProcess International - Feb 29, 2024

Orchard Therapeutics plc (NASDAQ: ORTX) - Share Price - intelligentinvestor.com.au

intelligentinvestor.com.au - Dec 28, 2024

Orchard Therapeutics hires ex-PTC executive Mark Rothera as new CEO - Fierce Biotech

Fierce Biotech - Aug 10, 2017

Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy - bloomberg.com

bloomberg.com - Mar 06, 2018

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment